Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation
Abstract Objective Gut microbiota might play a crucial role in the pathogenesis of irritable bowel syndrome (IBS), and probiotics supplement may be an effective treatment option. This study aims to explore the therapeutic effects of Golden bifid on the diarrhea-predominant IBS (IBS-D). Methods Twent...
Saved in:
Main Authors: | Mei Luo (Author), Qin Liu (Author), Lin Xiao (Author), Li-Shou Xiong (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
by: Özdener AE, et al.
Published: (2017) -
Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation
by: Junchen Li, et al.
Published: (2018) -
Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
by: Sobolewska-Włodarczyk A, et al.
Published: (2016) -
An Integrated Gut Microbiota and Network Pharmacology Study on Fuzi-Lizhong Pill for Treating Diarrhea-Predominant Irritable Bowel Syndrome
by: Zhang Zhen, et al.
Published: (2021) -
Serum-derived bovine immunoglobulin for children with diarrhea-predominant irritable bowel syndrome
by: Arrouk R, et al.
Published: (2018)